Abstract
Pemphigus vulgaris (PV) is an autoimmune bullous disease of the skin and mucous membranes characterized by the presence of circulating and tissue-bound autoantibodies against keratinocyte cell surface antigens, specifically desmoglein (Dsg) 1 and 3. The pathogenic role of anti-Dsg antibodies is well-established, while the mechanism of blister formation is only partly defined. We have applied a previously developed method for the efficient immortalization of IgG+ memory B cells to identify novel target antigens in PV. A human monoclonal antibody reactive with a hitherto unreported non-Dsg antigen was isolated. Immunoprecipitation and immunoblotting studies with keratinocyte extracts indicated α-catenin as the putative antigen, then confirmed by immunoblotting on the recombinant protein. Four of ten PV sera reacted with recombinant α-catenin. Although the isolated human monoclonal antibody was per se unable to dissociate keratinocyte monolayers and also to synergize with a pathogenic antibody in vitro, further studies are warranted to assess its possible in vivo contribution in the multifactorial pathogenesis and heterogeneous manifestations of PV disease.
Highlights
Pemphigus vulgaris (PV) is a rare but highly disabling and, if untreated, almost always fatal immunobullous disease of the skin and mucous membranes
The patients showed typical clinical, histological, and immunopathological features and had high-titer anti-Dsg circulating autoantibodies (PVC: Dsg3, 127 U/ml, Dsg1, 90 U/ml; PVF: Dsg3, 191 U/ml, Dsg1, 170 U/ml), as assessed by Enzyme Linked ImmunoSorbent Assay (ELISA) kits based on ectodomain of Dsg1 and Dsg3 (MBL, Nagoya, Japan). human monoclonal antibodies (hMabs) were isolated by a highly-efficient protocol for the immortalization of IgG+ memory B cell with Epstein Barr virus (EBV) in the presence of a Toll-like receptor agonist, as previously described [2]
The polyclonal antibodies produced by the vast majority of isolated cultures bound to surface antigens on the keratinocyte membrane and were reactive with Dsg1 and/or Dsg3 ectodomains by ELISA, as previously reported (2, and data not shown)
Summary
Pemphigus vulgaris (PV) is a rare but highly disabling and, if untreated, almost always fatal immunobullous disease of the skin and mucous membranes. PV is considered as a paradigmatic organ-specific autoimmune disease in view of (i) present knowledge of disease autoantigens and pathogenesis and (ii) reproducibility of major clinical and pathogenic features in animal models [1]. The existence of both pathogenic and non-pathogenic antiDsg autoAbs has recently been underscored by isolation of human monoclonal antibodies (hMabs) from pemphigus patients. Anti-Dsg hMabs characterization has shown that their pathogenic potential primarily depends on the targeted epitopes [1]. We have been interested in characterizing the repertoire of naturally occurring autoreactive epithelium-specific memory B cells in pemphigus vulgaris patients. (i) the lack of tight correlation between anti-Dsg autoAb titers and disease activity in some patients and (ii) the significant degree of disease heterogeneity point at the importance
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have